The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma

The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma

Yintao Wu,* Jianyong Zhu,* Hong Zhang, Nianxin Xia Senior Department of Hepato-Pancreato-Biliary Surgery, the First Medical Center of PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors contributed equally to this workCorrespondence: Nianxin Xia, S...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu Y, Zhu J, Zhang H, Xia N
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Cancer Management and Research
Subjects:
unresectable hepatocellular carcinomas
drug-eluting beads-transarterial chemoembolization-hepatic arterial infusion chemotherapy
clinical efficacy
prognosis
Online Access:https://www.dovepress.com/the-combination-of-d-tace-haic-lenvatinib-and-pd-1-inhibitors-shows-si-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/the-combination-of-d-tace-haic-lenvatinib-and-pd-1-inhibitors-shows-si-peer-reviewed-fulltext-article-CMAR

Similar Items